Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Major Depressive Disorder; Obsessive compulsive disorder Age: Adult |
Dose: Oral – Initially, 50 mg Frequency: once daily Note: may increase in increments of 50 mg at weekly intervals. Maximum: 200 mg daily. |
|
Indication: Panic disorder with or without agoraphobia; Posttraumatic stress disorder; Social anxiety disorder Age: Adult |
Dose: Oral – Initially, 25 mg Frequency: once daily Note: increased to 50 mg daily after a week. May increase in increments of 50 mg at weekly intervals. Maximum: 200 mg daily. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Obsessive compulsive disorder Age: Child: 6-12 years |
Dose: Oral – Initially, 25 mg Frequency: once daily Note: May increase at intervals of at least 1 week. Maximum: 200 mg daily. |
|
Indication: Obsessive compulsive disorder Age: 13-17 years |
Dose: Oral – Initially, 50 mg Frequency: once daily Note: May increase at intervals of at least 1 week. Maximum: 200 mg daily. |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Not specified Note: Dose adjustment not necessary |
Administration
- Can be taken with or without food
- Take at same time daily
Side Effect
- Diarrhea (13-24%)
- Nausea (13-30%)
- Headache (20-25%)
- Insomnia (12-28%)
- Ejaculation disorder (7-19%)
- Dizziness (6-17%)
- Dry mouth (6-16%)
- Fatigue (10-16%)
- Drowsiness (2-15%)
- Agitation (1-6%)
- Anorexia (5-10%)
- Anxiety (4%)
- Constipation (5-8%)
- Paresthesia (2%)
- Impotence (5-10%)
- Sweating (Less than 1%)
- Malaise (7-9%)
- Vomiting (4%)
- Pain (3-6%)
- Asthenia
- Back pain
- Chest pain
- Hypoesthesia
- Increased appetite
- Myalgia
- Palpitations
- Rhinitis
- Tinnitus
- Weight gain
- Yawning
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Antimuscarinics (Atropine, Hyoscine, Ipratropium)
|
May increase risk of delirium
|
|
Aripiprazole
|
Increased risk of extrapyramidal symptoms and neuroleptic malignant syndrome
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Hypersensitivity
|
Risk of severe allergic reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Do not store above 30°C. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.